BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Papp M, Foldi I, Altorjay I, Palyu E, Udvardy M, Tumpek J, Sipka S, Korponay-Szabo IR, Nemes E, Veres G, Dinya T, Tordai A, Andrikovics H, Norman GL, Lakatos PL. Anti-microbial antibodies in celiac disease: Trick or treat? World J Gastroenterol 2009; 15(31): 3891-3900 [PMID: 19701969 DOI: 10.3748/wjg.15.3891]
URL: https://www.wjgnet.com/1007-9327/full/v15/i31/3891.htm
Number Citing Articles
Boualem Sendid, Christopher Cao, Jean-Frederic Colombel, Daniel Poulain. Coincidence of antibodies against Hwp1 and ASCA, two distinct molecular targets of Candida albicans , reinforces the link between this fungal species and coeliac disease Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2334085
Marion Corouge, Séverine Loridant, Chantal Fradin, Julia Salleron, Sébastien Damiens, Maria Dolores Moragues, Vianney Souplet, Thierry Jouault, Raymond Robert, Sylvain Dubucquoi, Boualem Sendid, Jean Fréderic Colombel, Daniel Poulain, Julian R Naglik. Humoral Immunity Links Candida albicans Infection and Celiac DiseasePLOS ONE 2015; 10(3): e0121776 doi: 10.1371/journal.pone.0121776
A. Eser, P. Papay, C. Primas, E. Pernicka, M. Harrer, C. Dejaco, G. Novacek, C. Lichtenberger, S. Angelberger, L. Kazemi, A. Mikulits, H. Vogelsang, W. Reinisch. The impact of intestinal resection on serum levels of anti‐Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s diseaseAlimentary Pharmacology & Therapeutics 2012; 35(2): 292 doi: 10.1111/j.1365-2036.2011.04932.x
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield, Gemma Marceniuk. Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness studyHealth Technology Assessment 2021; 25(23): 1 doi: 10.3310/hta25230
Giulia Gasparini, Emanuele Cozzani, Marzia Caproni, Emiliano Antiga, Alessio Signori, Aurora Parodi. Could anti-glycan antibodies be useful in dermatitis herpetiformis?European Journal of Dermatology 2019; 29(3): 322 doi: 10.1684/ejd.2019.3542
Peter Laszlo Lakatos, Maria Papp, Florian Rieder. Serologic Antiglycan Antibodies in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology 2011; 106(3): 406 doi: 10.1038/ajg.2010.505
Lerner Aaron, Matthias Torsten. Candida albicans in celiac disease: A wolf in sheep’s clothingAutoimmunity Reviews 2020; 19(9): 102621 doi: 10.1016/j.autrev.2020.102621
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs diseaseInflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
Tatiana Pochechueva, Francis Jacob, Andre Fedier, Viola Heinzelmann-Schwarz. Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput ApproachesMetabolites 2012; 2(4): 913 doi: 10.3390/metabo2040913
Marco Daperno, Fabiana Castiglione, Lissy de Ridder, Iris Dotan, Martti Färkkilä, Jon Florholmen, Gerald Fraser, Walter Fries, Xavier Hebuterne, Peter Laszlo Lakatos, Julián Panés, Jordi Rimola, Edouard Louis. Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2011; 5(5): 484 doi: 10.1016/j.crohns.2011.07.003
Pal Miheller, Lajos S Kiss, Mark Juhasz, Michael Mandel, Peter L Lakatos. Recommendations for identifying Crohn’s disease patients with poor prognosisExpert Review of Clinical Immunology 2013; 9(1): 65 doi: 10.1586/eci.12.86
Aaron Lerner, Shimon Reif. Infection and Autoimmunity2015; : 829 doi: 10.1016/B978-0-444-63269-2.00051-9
Aaron Lerner. Vaccines and Autoimmunity2015; : 301 doi: 10.1002/9781118663721.ch31
Jason M. Brenchley, Daniel C. Douek. Microbial Translocation Across the GI TractAnnual Review of Immunology 2012; 30(1): 149 doi: 10.1146/annurev-immunol-020711-075001